Several groups have reported that BM-derived mesenchymal stem cells from MM patients (MM-hMSCs) show a distinctive gene expression profile and an enhanced production of cytokines, including IL-6, DKK1, IL-1β, and SDF-1 [1-4]. Here, CXCL12 is linked to Miyoshi myopathy.